loadpatents
name:-0.012278079986572
name:-0.0064780712127686
name:-0.0046708583831787
Nagy; Eva Patent Filings

Nagy; Eva

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nagy; Eva.The latest application filed is for "fowl adenovirus 9 (fadv-9) vector system and associated methods".

Company Profile
3.7.10
  • Nagy; Eva - Guelph CA
  • Nagy; Eva - Puslinch CA
  • Nagy; Eva - Winnipeg CA
  • Nagy; Eva - Manitoba CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fowl Adenovirus 9 (fadv-9) Vector System And Associated Methods
App 20210317476 - Pei; Yanlong ;   et al.
2021-10-14
Avian oncolytic virus having modified sequences and uses thereof
Grant 10,829,786 - Kozak , et al. November 10, 2
2020-11-10
Avian Oncolytic Virus Having Modified Sequences And Uses Thereof
App 20200190538 - KOZAK; Robert ;   et al.
2020-06-18
Fowl Adenovirus 9 (fadv-9) Vector System And Associated Methods
App 20190153470 - PEI; Yanlong ;   et al.
2019-05-23
Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
Grant 9,119,834 - Nagy , et al. September 1, 2
2015-09-01
Non-pathogenic Serotype 4 Fowl Adenovirus (fadv-4) And Viral Vector Thereof
App 20140010834 - Nagy; Eva ;   et al.
2014-01-09
Therapeutic Uses of Glandular Kallikrein
App 20130089564 - Berczi; Istvan ;   et al.
2013-04-11
Engineered scFv against bovine herpes virus type I
Grant 8,383,115 - Kaushik , et al. February 26, 2
2013-02-26
Engineered scFv against Bovine Herpes Virus Type I
App 20100196375 - Kaushik; Azad Kumar ;   et al.
2010-08-05
Therapeutic uses of glandular kallikrein
App 20070224209 - Berczi; Istvan ;   et al.
2007-09-27
Therapeutic uses of glandular kallikrein
Grant 7,195,759 - Sabbadini , et al. March 27, 2
2007-03-27
Therapeutic uses of glandular kallikrein
App 20030216306 - Sabbadini, Edris ;   et al.
2003-11-20
Method for sensitization of cancer cells for killer cell mediated lysis
Grant 5,788,964 - Baral , et al. August 4, 1
1998-08-04
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed